Pharma sneezes at TGA rejection

By Megan Brodie 2 years ago | In Products, Regulatory
  • 2 years ago
Firebrick Pharma founders Peter Molloy and Stephen Goodall

2 March 2022 ASX newcomer Firebrick Pharma will file an appeal against a TGA decision…

This is subscriber-only content. Please login to continue reading.